Literature DB >> 1391954

Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461-610 (Lys 461 AAA-->stop TAA).

J Koopman1, F Haverkate, J Grimbergen, R Egbring, S T Lord.   

Abstract

In the A alpha-chain gene coding for an abnormal fibrinogen (fibrinogen Marburg) we identified a single base substitution (A-->T) that changes the codon A alpha 461 AAA (Lys) to TAA (Stop). The propositus was found to be homozygous for the mutation, whereas the father and five siblings were heterozygous, and three other siblings contained only the normal sequence. The stop codon at position 461 results in the deletion of the carboxyl-terminal segment A alpha 461-610. Purified fibrinogen Marburg contained an A alpha-chain with a relative molecular weight of approximately 47,000. The FpA release by thrombin was not affected by this deletion, whereas the fibrin polymerization was strongly decreased. The binding of endothelial cells to immobilized fibrinogen Marburg was almost completely abolished compared with normal fibrinogen. Fibrinogen Marburg contained a substantial amount of albumin linked to the fibrinogen molecule by disulfide bonds, and these fibrinogen-albumin complexes were also present in plasma. The plasma fibrinogen concentration of the propositus was measured by three different methods: a functional method (< 0.25 mg/mL), an immunologic method using polyclonal antibodies (0.6 mg/mL), and an immunologic method based on two monoclonal antibodies specific for the amino-terminus and carboxyl-terminus of the A alpha-chain (< 0.05 mg/mL). Using the two immunologic methods, it appeared that only 10% to 15% of the plasma fibrinogen of the heterozygous siblings was abnormal.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1391954

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.

Authors:  Jean-Philippe Collet; Jennifer L Moen; Yuri I Veklich; Oleg V Gorkun; Susan T Lord; Gilles Montalescot; John W Weisel
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

2.  NMR solution structure, stability, and interaction of the recombinant bovine fibrinogen alphaC-domain fragment.

Authors:  Robert A Burton; Galina Tsurupa; Roy R Hantgan; Nico Tjandra; Leonid Medved
Journal:  Biochemistry       Date:  2007-06-23       Impact factor: 3.162

3.  Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other.

Authors:  Rustem I Litvinov; Sergiy Yakovlev; Galina Tsurupa; Oleg V Gorkun; Leonid Medved; John W Weisel
Journal:  Biochemistry       Date:  2007-07-13       Impact factor: 3.162

4.  Hypodysfibrinogenemia causing mild bleeding and thrombotic complications in a compound heterozygote of AalphaIVS4+1G>T mutation and Aalpha4841delC truncation (Aalpha(Perth)).

Authors:  Asier Jayo; Erin Arnold; Consuelo González-Manchón; David Green; Susan T Lord
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

5.  Molecular analysis of scabrous mutant alleles from Drosophila melanogaster indicates a secreted protein with two functional domains.

Authors:  X Hu; E C Lee; N E Baker
Journal:  Genetics       Date:  1995-10       Impact factor: 4.562

6.  Fibrinogen Dusart: electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots.

Authors:  J P Collet; J L Woodhead; J Soria; C Soria; M Mirshahi; J P Caen; J W Weisel
Journal:  Biophys J       Date:  1996-01       Impact factor: 4.033

Review 7.  Structure and function of human fibrinogen inferred from dysfibrinogens.

Authors:  Michio Matsuda; Teruko Sugo
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

8.  A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice.

Authors:  V A Ploplis; J Wilberding; L McLennan; Z Liang; I Cornelissen; M E DeFord; E D Rosen; F J Castellino
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

9.  Fib420: a normal human variant of fibrinogen with two extended alpha chains.

Authors:  Y Fu; G Grieninger
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

10.  Hereditary renal amyloidosis with a novel variant fibrinogen.

Authors:  T Uemichi; J J Liepnieks; M D Benson
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.